ArticlePloS one2019

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).

Thomas Prukop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.